275 related articles for article (PubMed ID: 32825955)
1. METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway.
Hou H; Zhao H; Yu X; Cong P; Zhou Y; Jiang Y; Cheng Y
Pathol Res Pract; 2020 Sep; 216(9):153087. PubMed ID: 32825955
[TBL] [Abstract][Full Text] [Related]
2. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
3. Mettl3 regulates the proliferation, migration and invasion of glioma cells by inhibiting PI3K/Akt signaling pathway.
Ji JW; Zhang YD; Lai YJ; Huang CG
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3818-3828. PubMed ID: 32329858
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
5. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract][Full Text] [Related]
6. RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells.
Sun P; Li L; Li Z
Biomed Res Int; 2020; 2020():5691671. PubMed ID: 32420351
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway.
Jia J; Yu L
Environ Toxicol; 2024 May; 39(5):2830-2841. PubMed ID: 38293837
[TBL] [Abstract][Full Text] [Related]
8. METTL3 regulates FAM83D m
Yu X; Li Y; Kong F; Xu Q
Toxicol In Vitro; 2024 Mar; 95():105746. PubMed ID: 38043628
[TBL] [Abstract][Full Text] [Related]
9. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
10. HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.
Zang B; Huang G; Wang X; Zheng S
Int J Clin Exp Pathol; 2015; 8(10):13687-94. PubMed ID: 26722596
[TBL] [Abstract][Full Text] [Related]
11. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
12. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
[TBL] [Abstract][Full Text] [Related]
13. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.
Liang H; Fang C; Zhang L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C770-C779. PubMed ID: 37575058
[TBL] [Abstract][Full Text] [Related]
14. METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway.
Liang S; Guan H; Lin X; Li N; Geng F; Li J
Oncol Lett; 2020 Apr; 19(4):3197-3204. PubMed ID: 32256816
[TBL] [Abstract][Full Text] [Related]
15. The METTL3-m
Qiu Y; Tian Z; Miao TY; Shen L; Chen J; Li PF; Zhu ZX; Zhu ZF; Wu WJ; Xu X; Shen WG
Gene; 2024 May; 908():148281. PubMed ID: 38360124
[TBL] [Abstract][Full Text] [Related]
16. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N
Wang W; Shao F; Yang X; Wang J; Zhu R; Yang Y; Zhao G; Guo D; Sun Y; Wang J; Xue Q; Gao S; Gao Y; He J; Lu Z
Nat Commun; 2021 Jun; 12(1):3803. PubMed ID: 34155197
[TBL] [Abstract][Full Text] [Related]
17. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
[TBL] [Abstract][Full Text] [Related]
18. The m
Cheng M; Sheng L; Gao Q; Xiong Q; Zhang H; Wu M; Liang Y; Zhu F; Zhang Y; Zhang X; Yuan Q; Li Y
Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266
[TBL] [Abstract][Full Text] [Related]
19. METTL3 Promotes the Proliferation and Mobility of Gastric Cancer Cells.
Lin S; Liu J; Jiang W; Wang P; Sun C; Wang X; Chen Y; Wang H
Open Med (Wars); 2019; 14():25-31. PubMed ID: 30886897
[TBL] [Abstract][Full Text] [Related]
20. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Wang A; Chen X; Li D; Yang L; Jiang J
J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
